After decades of neglect, sickle cell disease could soon be transformed with gene-based therapies
Two rival gene-based treatments developed by three biotech firms with headquarters, or most of their operations, in Mass. could be approved late this year or early in 2024.
United States University Of Alabama At Birmingham University Of Alabama Amanda Stults Patrick Mcgann Julie Kanter
Source: bostonglobe.com